Ada offers an AI‑driven symptom assessment platform that guides users through a personalized questionnaire and provides evidence‑based insights on possible conditions, self‑care steps, and appropriate care pathways. The service integrates with health‑system, payer, and pharma workflows via APIs, enabling a digital front door for early intervention and patient engagement across multiple languages.
Funding
$30M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many individuals struggle to obtain reliable, timely information about their symptoms, leading to delayed care, unnecessary emergency visits, or reliance on inaccurate online sources.
Solution
Ada provides an AI-powered symptom assessment platform that guides users through a personalized health questionnaire, leveraging clinically reviewed medical knowledge and clinician‑optimized algorithms. The tool delivers clear, actionable insights about possible conditions, recommended self‑care steps, and guidance on appropriate care pathways. By integrating with health‑system workflows and payer or pharma solutions, Ada can serve as a digital front door, directing patients to the right level of care and supporting early intervention. The platform also offers a multilingual medical library to help users understand health topics and make informed decisions.
Target Audience
Primary users are consumers seeking self‑assessment of symptoms, while health systems, insurers, and pharmaceutical companies use Ada to streamline care navigation and patient engagement.
Features
- AI-driven interview that adapts questions in real time based on user responses to improve diagnostic accuracy
- Medical library curated by doctors, covering a broad range of conditions and symptoms in easy‑to‑understand language
- Clinician‑validated algorithms with evidence showing high concordance with physician diagnoses
- Integration APIs for health systems, payers, and pharmaceutical partners to embed the assessment into existing digital pathways
- Multilingual support and accessibility features to reach diverse user populations
- Data security and privacy compliance, with encrypted transmission of assessment results